i highly doubt that they will be doing the p2 for tbi in 2024, no indication from management that this is the case. Good question for management at next conference call though for sure.
My main concern is funding.
- Forums
- ASX - By Stock
- Ann: Invex Granted European Orphan Drug Designation for TBI
i highly doubt that they will be doing the p2 for tbi in 2024,...
-
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
|
|||||
Last
6.0¢ |
Change
-0.007(10.5%) |
Mkt cap ! $4.509M |
Open | High | Low | Value | Volume |
6.0¢ | 6.0¢ | 6.0¢ | $3.264K | 54.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 600 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 600 | 0.060 |
1 | 15002 | 0.052 |
2 | 410000 | 0.051 |
1 | 200000 | 0.050 |
1 | 60001 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 20000 | 1 |
0.077 | 7950 | 1 |
0.078 | 20000 | 1 |
0.081 | 888 | 1 |
0.083 | 5724 | 2 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online